Gateway Investment Advisers LLC Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gateway Investment Advisers LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 109,554 shares of the medical equipment provider's stock after selling 2,783 shares during the period. Gateway Investment Advisers LLC's holdings in Intuitive Surgical were worth $57,183,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at $33,000. Mark Sheptoff Financial Planning LLC bought a new position in Intuitive Surgical in the second quarter valued at about $37,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the third quarter worth about $38,000. Finally, DT Investment Partners LLC grew its stake in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares during the period. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ISRG. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James raised their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. Finally, Piper Sandler reissued an "overweight" rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $554.17.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of the firm's stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company's stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $3.97 during mid-day trading on Thursday, hitting $584.08. The company had a trading volume of 2,119,290 shares, compared to its average volume of 1,655,838. The stock's 50 day moving average price is $538.34 and its 200-day moving average price is $497.08. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $585.50. The company has a market capitalization of $208.04 billion, a P/E ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.